<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Cambridge MedTech Foundation - Medium]]></title>
        <description><![CDATA[We are a student-run society at the University of Cambridge with the aim to educate, inspire and connect the next generation of healthcare innovators. We run an educational Innovation Programme, organise MEDx talks with MedTech leaders and foster innovation amongst students. - Medium]]></description>
        <link>https://medium.com/cambridge-medtech-foundation?source=rss----b4599aa1c18a---4</link>
        <image>
            <url>https://cdn-images-1.medium.com/proxy/1*TGH72Nnw24QL3iV9IOm4VA.png</url>
            <title>Cambridge MedTech Foundation - Medium</title>
            <link>https://medium.com/cambridge-medtech-foundation?source=rss----b4599aa1c18a---4</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Wed, 18 Nov 2026 08:05:53 GMT</lastBuildDate>
        <atom:link href="https://medium.com/feed/cambridge-medtech-foundation" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Medical Technology in the Lower and Middle-Income Countries]]></title>
            <link>https://medium.com/cambridge-medtech-foundation/medical-technology-in-the-lower-and-middle-income-countries-cbc4006cb7f8?source=rss----b4599aa1c18a---4</link>
            <guid isPermaLink="false">https://medium.com/p/cbc4006cb7f8</guid>
            <category><![CDATA[articles]]></category>
            <category><![CDATA[lmic]]></category>
            <category><![CDATA[medical-technology]]></category>
            <dc:creator><![CDATA[Bishow Bekhyat Karki]]></dc:creator>
            <pubDate>Mon, 05 Apr 2021 08:07:52 GMT</pubDate>
            <atom:updated>2021-04-05T08:07:52.665Z</atom:updated>
            <content:encoded><![CDATA[<p>The New Public Health (Third Edition), 2014, defines Medical Technology as “The application of science to develop solutions to health problems or issues such as the prevention or delay of onset of diseases or the promotion and monitoring of good health”. This definition includes medical and surgical procedures, drugs, equipment &amp; facilities, and the organisational &amp; supportive systems within which health care is provided [1]. Lower-middle-income countries (LMICs) are those having $1,006 to $3,955 GNI per capita, as defined by The World Bank Group. Medical technologies are still beyond the reach for the majority of people living in the LMICs. Despite the resource limitations, these countries are opting the possible systems for the enhancement and use of medical technology by collaborating with various national and international agencies. Medical technology has flourished into the depths over the course of many centuries. However, medical technology has evolved magnitude more extensively in the last two decades than in the past couple of centuries. The technological advancements in the medical field has allowed for a high level of patient care by allowing quicker diagnosis, less pain and reduced costs, which in the end will help save more lives [2].</p><p>LMICs share many common issues, including inadequate access of the population to health services, a relatively weak national industry for production of drugs and medical devices, a weak policy structure for dealing with medical technology, and little tradition of using research or policy analysis as a guide to action [3]. A lack of health technology is an obstacle to health system growth in LMICs [4]. Many health outcomes are directly dependent on access to healthcare technologies, and yet barriers to access these technologies are high and substantial in LMICs [5]. The difficulties experienced in the transfer of medical technology are aggravated by partial and incomplete understanding of the cultural, social, economic, and institutional factors affecting technology development, transfer, dissemination and use [6].</p><p>The ground reality in these countries is alarming. As the services are especially centred in the major cities and towns, the rural areas are deprived of the basic health services with very limited technological applications which has significantly affected the healthcare delivery system in the remote areas. Most of the rural areas are still connected by the transportation network which has caused a great barrier in prompt responses during a healthcare crisis. However, starting recently, the uses of mobile technology for consultation, telemedicine, and use of drones in the delivery of medicines in remote areas have shown promising results given the critical shortage of health workers and poor distribution of service providers in many LMICs [7].</p><p>Since it’s an inarguable fact that medical technology has revolutionised the way healthcare services are provided in the current world, its impact on the health care system in LMICs is even more prominent. Technological assessments, international aids, technological support, Roles of NGO, International mandates are the few variables that can play a determining part in changing the Health care in the LMICs. With appropriate technological supports and assessments, there will be a constant check and balance in the further health needs and service provisions. Appropriate technical collaboration, which can be achieved via establishing and supporting innovation centers, between the developed countries and the LMICs is much needed. International organisations advocating for global health provisions must be active in assisting such countries in improving decisions concerning MedTech as the regulations concerning these are very centralised. In the country with the hilly and mountainous terrain integrated use of telemedicine between various health hubs in the region could act as a milestone for health service enhancement as it replaces a traditional office visit and extends the geographic access.</p><p>Citations:</p><p>[1] <a href="https://www.sciencedirect.com/topics/social-sciences/medical-technology">https://www.sciencedirect.com/topics/social-sciences/medical-technology</a></p><p>2 <a href="https://www.bartleby.com/essay/Advances-in-Medical-Technology-FKCUUR6STC">https://www.bartleby.com/essay/Advances-in-Medical-Technology-FKCUUR6STC</a></p><p>3 Banta HD. Medical technology and developing countries: the case of Brazil. Int J Health Serv. 1986;16(3):363–73. doi: 10.2190/7H41-XEEB-AQYY-0CN6. PMID: 3733305</p><p>4 AMA J Ethics. 2019;21(9):E735–741. doi: 10.1001/amajethics.2019.735.</p><p>5 AMA J Ethics. 2019;21(9):E735–741. doi: 10.1001/amajethics.2019.735.</p><p>6 Medical technologies in developing countries: Issues of technology development, transfer, diffusion and use,</p><p>7 Lewis T, Synowiec C, Lagomarsino G, Schweitzer J. E-health in low- and middle-income countries: findings from the Center for Health Market Innovations. Bull World Health Organ. 2012;90(5):332–340. doi:10.2471/BLT.11.099820</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=cbc4006cb7f8" width="1" height="1" alt=""><hr><p><a href="https://medium.com/cambridge-medtech-foundation/medical-technology-in-the-lower-and-middle-income-countries-cbc4006cb7f8">Medical Technology in the Lower and Middle-Income Countries</a> was originally published in <a href="https://medium.com/cambridge-medtech-foundation">Cambridge MedTech Foundation</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Special Interview with Dr. Mahabir Pun]]></title>
            <link>https://medium.com/cambridge-medtech-foundation/special-interview-with-dr-mahabir-pun-5d038c1952e0?source=rss----b4599aa1c18a---4</link>
            <guid isPermaLink="false">https://medium.com/p/5d038c1952e0</guid>
            <category><![CDATA[lmic]]></category>
            <category><![CDATA[medical-technology]]></category>
            <category><![CDATA[interview]]></category>
            <dc:creator><![CDATA[Bishow Bekhyat Karki]]></dc:creator>
            <pubDate>Mon, 05 Apr 2021 08:07:05 GMT</pubDate>
            <atom:updated>2021-04-05T08:07:05.644Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Interview with Dr. Mahabir Pun</strong></h3><p><em>Bishow Bekhyat Karki (CamMTF External Officer) speaks to Dr. Mahabir Pun to discuss the role of Medical Technology in enhancing health care in LMIC’s .</em></p><p><em>Dr. Mahabir Pun is a Nepali scientist, teacher, social entrepreneur and an activist known for his extensive work in applying wireless technologies to develop remote areas of the Himalayas. Also, he has led an initiative to establish a non-profit organisation, National Innovation Centre, whose primary objective is to foster research and development for the economical development of the country. Among several international recognition, Dr. Pun was awarded the Magsaysay Award in 2007, considered the Nobel Prize of Asia in recognition of his innovative applications of wireless computer technology in Nepal , bringing progress to the remote mountainous areas by connecting rural villages to the global villages.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/440/0*tbDrLCYaOPKZ3e6e" /><figcaption>Pic Source : Wikipedia (Dr. Mahabir Pun)</figcaption></figure><p><strong>What is the current status of Medical Technology application in the Lower- and Middle-Income countries (LMICs)?</strong></p><p>To start with, in the LMICs, there are two very different outcomes in all the healthcare services. In the urban areas, there are private hospitals which have the medical technology application. On the other hand, in the rural settings the situation is much more limited in terms of the use of medical technology. Rural areas lack proper health services and the government funded hospitals lack appropriate services and maintenance. The sadder part is that in the rural areas, there are not enough medical personnel, they only have small clinics mostly run by auxiliary health workers. So overall, the situation is very unsatisfying.</p><p><strong>What is the role of medical technology in enhancing healthcare, especially in the low and middle income countries?</strong></p><p>Medical technology enhances the service to the patient by adding values which are much needed in the LMICs because of the lack of skilled manpower especially in the rural setting. MedTech can be used in varied ways to provide health services to the remote hilly areas and mountainous part of the country.</p><p><strong>As a chairman and founder of the national Innovation Centre, what are the projects you are currently working on in terms of enhancing MedTech in the country?</strong></p><p>Firstly, the National Innovation Centre is a platform for people with innovative ideas from any field, any education background, to come and work to test whether those ideas have the potential to be commercialised. We help them to develop prototypes and products while ensuring they have full rights on the intellectual property. Our reason behind this is to avoid draining the intellectual mind from the LMICs to the developed countries.</p><p>During the pandemic, we focused on protecting our healthcare workers by developing various low resource setting PPE’s and distributing it free of cost. We have COVID Swab Collection Booth, Aerosol Booth, Ventilators, Robots to serve medications and food in the COVID Wards. Also, we ran a project to repair dialysis machine, oxygen concentrators in the hospitals of Rural Areas. Ath the same time, we recently developed an Electronic Health Recording System for hospitals. Working with ophthalmology and Orthopaedic Surgeon on the development of novel devices. Along with the graduates from Stanford University, we are developing various prototypes of medical devices.</p><p><strong>As the Innovation Centre also worked on prototype medical drones in collaboration with UNICEF capable of delivering medicine, how do you think it will impact on the health care system of the hilly and mountainous country?</strong></p><p>We have many villages in the remote mountainous and hilly regions which are still not connected to the transportation network. People still have to walk days to receive health care and medication. In order to provide the health service in an effective and efficient way, we developed the prototype of a medical drone along with UNICEF so that the patients don’t have to lose their life because of the lack of appropriate medication.</p><p><strong>While you were in the United States, you had recognised that information technology had the potential to transform the education system and the economy of the various regions in the country. Do you think you could link those aspects into developing the health sector and working in advancement of medical technology?</strong></p><p>After my graduation, I returned back to my village, which is one of the remote regions of the country, and started working as a community developer on local projects. Communication among the villages was very difficult so I decided to build wireless networks in the remote mountain villages in 2000. Initially it was used solely for communication purposes but later developed the model of health consultation. So, whenever someone was sick in the village we could consult easily with the doctors in Kathmandu and other major cities. This is how telemedicine services were initiated in remote areas of the country. Following this model, we now are working in the development of “Resilient Healthcare System” in the remote villages where there is the presence of at least one doctor, two nurses, lab technicians, mini operating rooms, services of X-Ray and USG. So this medical hub will be connected to several others in the region. With the help of telemedicine, each hub can connect with others for advice and other services. Especially , as it is very difficult to build health centres in rural villages and we lack skill professionals to serve in all these areas.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/675/0*eWzRDuN5-18gzPRC" /><figcaption>Pic Source : MadeInNepal</figcaption></figure><p><strong>Are there any opportunities for our audience to get involved with the projects of the National Innovation Centre if they want to intern/help/ experience how medical technology is turning the wheel of healthcare in LMIC countries?</strong></p><p>We welcome everyone around the globe to be a part of our initiative. We have been collaborating with various institutions on several projects. We also have been sharing the expertise with undergrad/grad students from national and international Universities. It’s not necessary to be physically here but we can connect digitally sharing ideas and expertise. We are open to any institution, any individual or any group which benefits all.</p><p><strong>Is there anything you want to express to our audience who wants to work/contribute in the field of Medical Technology?</strong></p><p>At the Innovation Centre, we aim to involve people from every background all over the world who have innovative ideas and who aim to do something good for humanity. We also provide bursaries and support. Even though it’s not much, we intend to inspire the young minds. We are funded by the people for the general public. You are always welcome in this Himalayan Nation to do something great together.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5d038c1952e0" width="1" height="1" alt=""><hr><p><a href="https://medium.com/cambridge-medtech-foundation/special-interview-with-dr-mahabir-pun-5d038c1952e0">Special Interview with Dr. Mahabir Pun</a> was originally published in <a href="https://medium.com/cambridge-medtech-foundation">Cambridge MedTech Foundation</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[MEDx 5 Summary — Surgical Robots: Assisting or Becoming the Surgeon?]]></title>
            <link>https://medium.com/cambridge-medtech-foundation/with-overwhelming-support-from-our-previous-medx-on-the-topics-of-medical-digitalisation-the-8271bc3c39c8?source=rss----b4599aa1c18a---4</link>
            <guid isPermaLink="false">https://medium.com/p/8271bc3c39c8</guid>
            <category><![CDATA[surgical-technology]]></category>
            <category><![CDATA[surgery]]></category>
            <category><![CDATA[speakers]]></category>
            <category><![CDATA[medtech]]></category>
            <category><![CDATA[medical-technology]]></category>
            <dc:creator><![CDATA[Sze Mai Ng]]></dc:creator>
            <pubDate>Sun, 21 Mar 2021 20:37:14 GMT</pubDate>
            <atom:updated>2021-03-21T21:14:55.269Z</atom:updated>
            <content:encoded><![CDATA[<h3>MEDx 5 Summary — Surgical Robots: Assisting or Becoming the Surgeon?</h3><h4>How is the “disappearing computers” analogy applicable to surgical robotics? Can surgical robots play a role in “teaching” surgeons of the next generation? Just how much $$$ is the development of surgical robotics worth? And… in the future, will surgical robots assist or BECOME the surgeon? Interested to know the answers? Scroll down to find out more about the insightful debates on surgical robotics presented by our expert panelists!</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*x9GOpqOodX8YbRVKR1L6NA.png" /><figcaption>MEDx #5 Event Banner.</figcaption></figure><p>With overwhelming support from our previous MEDx on the topics of medical digitalisation, the Cambridge MedTech Foundation continued with a fifth addition to our series — an engaging panel discussion on surgical robotics, with over 50 participants from medicine, engineering, entrepreneurship and more other disciplines. We were delighted to have thought-provoking contributions from our three expert panelists — Mr Hani Marcus, an academic consultant keyhole neurosurgeon; Luke Hares, Chief Technology Officer at CMR Surgical; and Mr Nikhil Vasdev, a consultant urological and robotic surgeon.</p><p>The panel discussion began with an in-depth exploration of autonomous robotic surgery — “Assisting or Becoming the Surgeon?” — with each panelist pitching forward an unique perspective from their respective area of specialty, presenting heated debates in the field such as the varying difficulties of AI in managing patients’ anatomical variations and real-time decision-making in different fields of surgery. On the other hand, the panelists enthusiastically presented the topics of the enormous potential in robotic surgery waiting to be uncovered, being in its infancy with room for boundless improvement.</p><p>The discussion further latched onto the similarities and differences between surgical robotics and other sprouting fields of technology. Seeing how far humanity has come from fully manually operated vehicles to the development of anti-lock braking and real-time global positioning systems, which safeguard against danger and assist drivers in decision-making, the panelists shed lights on the potential of AI to guide practicing surgeons through safety checklists and deliver overlooked warnings or emergency interventions, which highlights the prospective role of surgical robots in surgical pedagogy and risk prevention. It was suggested that the future development of surgical robotics may resonate with the “disappearing computers” phenomenon, giving rise to more compact and efficient robotic systems with lower production costs.</p><p>The pragmatic issue of cost then provoked a multi-sided debate from technological, clinical and global perspectives, raising questions regarding the cost-effectiveness of surgical robotics in terms of holistic patient care, accessibility, frequency and ease of usage. Though the potential is vast in open-source collaboration between the diverse array of investors and developers, the panelists suggested that there are still obstacles to be overcome in their respective fields of expertise, such as the development of an unanimous regulatory framework, cross-platform compatibility and standardisation of technique. Further disagreement was raised on the topic of haptic and tactile feedback, being a clinically essential yet technologically taxing addition to surgical robotic systems.</p><p>The event culminated with some amazing questions from our audience, and intriguing food for thought on the budding field of surgical robotics, being scientifically demanding yet humanistically intertwined. Such an exciting edition of MEDx would not have been possible without the generous contributions from our panelists and enthusiastic participation of our audience. Thank you so much for coming, and we hope to see you again at our future events!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8271bc3c39c8" width="1" height="1" alt=""><hr><p><a href="https://medium.com/cambridge-medtech-foundation/with-overwhelming-support-from-our-previous-medx-on-the-topics-of-medical-digitalisation-the-8271bc3c39c8">MEDx 5 Summary — Surgical Robots: Assisting or Becoming the Surgeon?</a> was originally published in <a href="https://medium.com/cambridge-medtech-foundation">Cambridge MedTech Foundation</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[CamMTF — Q&A with Cambridge Medic & Biotech Enthusiast]]></title>
            <link>https://medium.com/cambridge-medtech-foundation/cammtf-q-a-with-cambridge-medic-biotech-enthusiast-9f1eb823fc23?source=rss----b4599aa1c18a---4</link>
            <guid isPermaLink="false">https://medium.com/p/9f1eb823fc23</guid>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[cambridge]]></category>
            <category><![CDATA[medical-technology]]></category>
            <category><![CDATA[biotechnology]]></category>
            <category><![CDATA[interview]]></category>
            <dc:creator><![CDATA[Sze Mai Ng]]></dc:creator>
            <pubDate>Thu, 18 Mar 2021 16:14:39 GMT</pubDate>
            <atom:updated>2021-03-18T16:17:25.366Z</atom:updated>
            <content:encoded><![CDATA[<h3>Q&amp;A with Cambridge Medic &amp; Biotech Enthusiast</h3><p>Interested to hear views from a Cambridge Medical student on getting involved with Biotechnology through internships and startups? Read our Q&amp;A to know more.</p><blockquote>Sze Mai Ng (CamMTF External Officer) speaks to Christopher Mak (a Year 3 Cambridge University medical student) to discuss his views on medical technology, experiences with internships and founding biotech startups, as well as his future career prospects in the field.</blockquote><p>Sze Mai: Thanks a lot for taking the time to speak to us, Christopher. To start off, we’d like to know your general views on medical technology. Could you define medical technology in your own words?</p><p>Christopher: Sure. Medical technology is the use of devices and manufacturing processes to solve existing medical problems. At present, a lot of it seems to revolve around surgery and blood diagnostics, but I’m not sure if this will change in the future.</p><p>Sze Mai: Of course, with its exponential growth, the future of technology holds endless possibilities. It seems to me that you know a lot about MedTech — on that note, I wonder whether you have heard of the Innovation Programme (IP) organized by our society?</p><p>Christopher: Unfortunately, I have not heard of the IP.</p><p>(Sze Mai sends Christopher a link (<a href="https://cam.medtechfoundation.org/index.php/ip/">https://cam.medtechfoundation.org/index.php/ip/</a>) to a brief overview of the IP on our website, of which he takes a quick look.)</p><p><a href="https://cam.medtechfoundation.org/index.php/ip/">Innovation Programme</a></p><p>It seems very interesting to me! I would be quite keen on participating in the future, just need more time to look into the details.</p><p>Sze Mai: That’s great to know! The IP is definitely a valuable educational programme for anyone interested in medical innovation, which, from what I have heard, you’ve got plenty of experience in. Could you briefly share with us about your previous internships in the field of biotechnology?</p><p>Christopher: No problem. In my first year of medical school here at Cambridge, I spent the summer in Cambridge Stem Cell Institute. I took part in investigating stem cell applications in tissue engineering and bioengineering, in particular, how stem cells can be used to repair knees in situ as a substitute for total knee replacement. With my experience in first year, in the next summer I had the privilege of studying genetic architecture at Harvard Stem Cell Institute, as well as conducting neuroscience research at F.M Kirby Neurobiology Center.</p><p>Sze Mai: Whoa, you’ve accomplished so much despite the hectic schedule of Cambridge’s preclinical course, that’s really inspirational for future students. Besides work experiences, I’ve also heard about your startup and would love to know more about it!</p><p>Christopher: Glad to hear that — MedTech is definitely loads of hard work and dedication, but it’s a deeply fascinating discipline that I enjoy working on. My startup is called Oxbridge Organomics. The initial idea was formed based on advice from PhDs and masters in pharmacology and chemical engineering; I’ve also drawn inspiration from my previous internship experience. It is centered on using 3D organoids as models to study drug interactions, pharmacokinetics and pharmacodynamics, and how it might inform further drug discovery and development.</p><p>Sze Mai: I see, that’s such amazing work you’ve been doing! Organoid technology seems to be an intriguing topic with its far-reaching influences on personalised and regenerative medicine… Besides that, what future areas of development in MedTech do you anticipate to be of great potential?</p><p>Christopher: That’s a broad question indeed. Surgical technology and robotics would be one of the more definite answers, as I anticipate demand for those to be persistently high. Looking further into the future, there are 3 other fields for potential development that came to mind: (1) biogerontology, i.e. drugs related to aging; (2) anything related to the brain, such as neurodegeneration and neurorepair; (3) cancer, as seen from the emergence of organizations such as Cancer Research UK. All in all I’m quite optimistic about the future of MedTech!</p><p>Sze Mai: Thanks for the detailed answer — there’s lots of potential vested in the fields you mentioned, I’m sure. What about yourself, then? Have you considered working in any of these areas?</p><p>Christopher: Of course. As a medical student, I see my future self as a doctor, professor, or academic surgeon working part-time in the MedTech field; the continuation of my current startup may be a potential career option for me.</p><p>Sze Mai: It seems quite an ambitious career path which requires a solid academic foundation, skilful time management and extensive networking — but I’m sure all your tenacious efforts will prove more than worthwhile! Once again, a tremendous thank you for your insightful sharing. Wishing you all the best for your future plans!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9f1eb823fc23" width="1" height="1" alt=""><hr><p><a href="https://medium.com/cambridge-medtech-foundation/cammtf-q-a-with-cambridge-medic-biotech-enthusiast-9f1eb823fc23">CamMTF — Q&amp;A with Cambridge Medic &amp; Biotech Enthusiast</a> was originally published in <a href="https://medium.com/cambridge-medtech-foundation">Cambridge MedTech Foundation</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Innovation Programme 2020/21 — Introducing students to Medical Device Development]]></title>
            <link>https://medium.com/cambridge-medtech-foundation/innovation-programme-2020-21-introducing-students-to-medical-device-development-89fead5f7618?source=rss----b4599aa1c18a---4</link>
            <guid isPermaLink="false">https://medium.com/p/89fead5f7618</guid>
            <category><![CDATA[medtech]]></category>
            <category><![CDATA[medical-technology]]></category>
            <category><![CDATA[innovation-program]]></category>
            <category><![CDATA[cambridge]]></category>
            <category><![CDATA[innovation]]></category>
            <dc:creator><![CDATA[Daniel Kottmann]]></dc:creator>
            <pubDate>Tue, 23 Feb 2021 21:13:20 GMT</pubDate>
            <atom:updated>2021-02-23T21:13:20.655Z</atom:updated>
            <content:encoded><![CDATA[<h3>Innovation Programme 2020/21 — Introducing students to Medical Device Development</h3><blockquote><strong><em>“The Innovation Programme was an invaluable experience to see interdisciplinary work for innovation.”</em></strong></blockquote><blockquote>MPhil student in Bioscience Enterprise</blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*0AGLoy0ZqXXVyBtohuoBKg.png" /></figure><p>In a year when innovation in medicine is required more than ever, the third round of the Innovation Programme was delivered in a virtual format. <strong>36 students and doctors </strong>from the University of Cambridge and Cambridge/East of England hospitals, of which 28 were postgraduate students, participated.</p><p>Over the course of twelve weeks, six teams developed concepts for medical technology to solve clinical problems. The three problems this year were about burst abdomen, hip fracture rehabilitation, and large bore vascular access.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*udWAArGRCkpjGW13JggUhg.png" /></figure><p>This year’s cohort was very interdisciplinary, with most students studying sciences, medicine and more engineering and business students than in previous years. Each team was put together in a way that different backgrounds and career stages would work together.</p><p>Virtual workshops were delivered by our partners and covered a variety of topics related to medical device development. <strong>Dr Angela Lam</strong> (<em>North West Anglia NHS Foundation Trust</em>), <strong>Dr Stefan Mitrasinovic</strong> (<em>North West Anglia NHS Foundation Trust</em>), and <strong>Dr Stephen Hoole</strong> (<em>Royal Papworth Hospital NHS Foundation Trust</em>) presented the clinical problems in the first workshop and mentored the teams during the programme.</p><p><em>Abigail Bush</em> (<a href="https://www.cuh.nhs.uk/our-research/research-facilities/clinical-engineering/"><strong>Clinical Engineering Innovation</strong></a><em>, Cambridge University Hospitals NHS Foundation Trust</em>) provided an overview of concept generation, the innovation pathway and important regulatory aspects of medical devices. The team from <em>Clinical Engineering Innovation</em> also provided mentoring sessions in which teams discussed technical aspects of their ideas and received valuable feedback.</p><blockquote><strong><em>“Clinical Engineering Innovation’s in-depth knowledge helped us to refine our design and consider how the different features would connect to produce an effective device.”</em></strong></blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-RKJMI1RmncAn3hklDCuqw.png" /></figure><p><em>Andrew Hatcher</em> from the <a href="https://www.jbs.cam.ac.uk/entrepreneurship/"><strong>Entrepreneurship Centre at the Cambridge Judge Business School</strong></a><strong> </strong>gave two workshops about Opportunity Evaluation &amp; Effective Teamwork and the Business Model Canvas. He taught the teams how to create a business model, how to evaluate the market and gave examples of what an entrepreneurial journey in MedTech would involve.</p><p>Teams received business mentoring from <a href="https://startcodon.co/"><strong>startcodon</strong></a>, a Cambridge-based healthcare accelerator to develop their business plan further.</p><blockquote><strong><em>“The mentoring session with startcodon provided us with insights into how our product could be marketed and their expertise helped us to integrate the business model with our product early in the design phase.”</em></strong></blockquote><p>In a practical workshop, <em>Charlie Dean, Matt Chandler</em> and <em>Iain Ansell</em> from <a href="https://www.team-consulting.com/"><strong>Team Consulting</strong></a> covered the steps that are required after concept generation, to develop a final product. As a medical consultancy in Cambridge, they gave real-life examples from their work to outline the process of developing a medical device.</p><blockquote><strong><em>“The case studies that Team Consulting presented and hearing their industry expertise helped us to get a better idea of the route from concept to product.”</em></strong></blockquote><p>Finally, <strong>Simon Hall</strong> from the <a href="https://creative-warehouse.com/">Creative Warehouse</a> delivered a workshop on how to give a successful pitch to prepare the teams for their own pitches.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*fp24uX53ZYbkU4kUabYHVA.png" /></figure><p>All teams presented their final MedTech concepts at the Final Pitch Event in January to all participants of the programme and a panel of judges, consisting of <strong>Prof Andrew McCaskie</strong> (Head of Department of Surgery, University of Cambridge), <strong>Sakura Holloway</strong> (Head of Due Diligence, startcodon), and <strong>Iain Ansell</strong> (Head of Surgical, Team Consulting). The judges were particularly impressed with the high quality of pitches and with the innovative ideas that teams came up with within such a short time.</p><p>The panel selected <strong>AClosure</strong> (Arka Banerjee, Shiv Kapila, Kasey Lau, Emma Sun, Nicholas Wan, Sarah Wenyon) as the overall winner, and <strong>Soul</strong> (Lucy Chmelova, Harry Freeman, Elika Karvandi, Panagiotis Makris, Chandan Sanghera, Michael Yeung) as the runner-up of the programme. Both teams were invited to pitch their work at the <strong>Association of Surgeons in Training (ASiT) Annual Virtual Conference</strong> in March.</p><blockquote><strong><em>“The Innovation Programme was a fantastic experience and boosted my interest in having a career in MedTech.”</em></strong></blockquote><blockquote>3rd year medical student</blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*6w0FpBQHyYO4TGx4dfX8Xw.png" /></figure><p>The Innovation Programme 2020/21 was proudly supported by <a href="https://www.team-consulting.com/"><strong>Team Consulting</strong></a> and <a href="https://startcodon.co/"><strong>startcodon</strong></a>.</p><p>The programme was organised by the <a href="http://cam.medtechfoundation.org/">Cambridge MedTech Foundation</a>, <a href="https://www.linkedin.com/in/danielkottmann/"><strong>Daniel Kottmann</strong></a> (2nd year PhD student in Medicine), <strong>Will Foster </strong>(4th year MD/PhD student) and <a href="https://www.linkedin.com/in/manuela-r-zimmermann-a3b9551a3/"><strong>Manuela Zimmermann</strong></a> (3rd year PhD student in Biophysics). It was supported by our academic partners the <a href="https://surgicalmic.nihr.ac.uk/">NIHR Surgical MIC</a>, <a href="https://www.cuh.nhs.uk/our-research/research-facilities/clinical-engineering/">Clinical Engineering Innovation at Cambridge University Hospitals</a>, and the <a href="https://www.jbs.cam.ac.uk/entrepreneurship/">Entrepreneurship Centre at the Judge Business School</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*SQcHkORYvVbd-pxbSf1w2A.png" /></figure><p>Interested in applying to the programme or getting involved? <a href="https://cam.medtechfoundation.org/index.php/ip/">Visit our website to find out more.</a></p><p><strong>About the Innovation Programme</strong></p><p>The Innovation Programme is a 12-week educational programme providing both an introduction to the landscape of medical device development and experience of interdisciplinary teamwork. <a href="https://cam.medtechfoundation.org/index.php/ip/">Find out more.</a></p><p><strong>About the Cambridge MedTech Foundation</strong></p><p>We are a student-run society at the University of Cambridge with the aim to educate, inspire and connect the next generation of healthcare innovators. <a href="https://cam.medtechfoundation.org/">Visit our website.</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*nVqJn8MCjxt2k2HCbedQag.png" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=89fead5f7618" width="1" height="1" alt=""><hr><p><a href="https://medium.com/cambridge-medtech-foundation/innovation-programme-2020-21-introducing-students-to-medical-device-development-89fead5f7618">Innovation Programme 2020/21 — Introducing students to Medical Device Development</a> was originally published in <a href="https://medium.com/cambridge-medtech-foundation">Cambridge MedTech Foundation</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Interview with Mr Hani Marcus, an academic consultant neurosurgeon]]></title>
            <link>https://medium.com/cambridge-medtech-foundation/interview-with-mr-hani-marcus-an-academic-consultant-neurosurgeon-1d855b009723?source=rss----b4599aa1c18a---4</link>
            <guid isPermaLink="false">https://medium.com/p/1d855b009723</guid>
            <category><![CDATA[interview]]></category>
            <dc:creator><![CDATA[Cambridge MedTech Foundation]]></dc:creator>
            <pubDate>Tue, 16 Feb 2021 04:08:33 GMT</pubDate>
            <atom:updated>2021-02-16T04:08:33.529Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*RheAuBTpZ_ipcQAh" /></figure><h3>Interviewee Background</h3><p>Mr Hani J Marcus PhD FRCS</p><p>Consultant Neurosurgeon (Pituitary and Anterior Skull Base) | National Hospital for Neurology and Neurosurgery</p><p>Honorary Associate Professor (Robotics and AI) | UCL Queen Square Institute of Neurology</p><p>Lead for Neurosurgery and Brain Cancer (North Thames CRN) | National Institute for Health Research</p><h3><strong>Professional background</strong></h3><p>Mr Marcus is an academic consultant neurosurgeon, and was among the first cohort of trainees to be selected for a Walport Integrated Academic Training Pathway, with rotations at the University of Cambridge, Imperial College London, and University College London.</p><p>His clinical interest is in “keyhole” endoscopic neurosurgical approaches. To this end, he completed fellowships in endoscopy and anterior skull base surgery (including pituitary surgery) at the Klinik Hirslanden, Zurich and the National Hospital for Neurology and Neurosurgery. His research interest, and the subject of his doctoral thesis under Prof Lord Darzi, is the development and evaluation of new devices that makes these keyhole approaches more safe and effective, including augmented reality, robotics, and artificial intelligence.</p><p>His work has received over £1.5 million in research funding, has resulted in over 75 peer-reviewed publications, and has frequently featured in the national press. In recognition of these achievements he was commissioned by Springer to act as Editor on their first book dedicated to Neurosurgical Robotics, serves as a Member of the Advisory Group on Robotic Surgery in the United Kingdom, and has been awarded several prizes, including the prestigious Hunterian Professorship by the Royal College of Surgeons of England in 2019.</p><h3>Interview with Mr. Hani Marcus conducted on the 21st of October, 2020 by B. Karki</h3><ol><li><strong>How do you describe Med Tech and its role in the current climate?</strong> <br>I think the term MedTech is very broad and covers any technology used in healthcare. For instance, in the context of the COVID-19 pandemic, we have seen huge value in MedTech, where many collaborative initiatives between academia, healthcare, and industry, have resulted in rapid developments and 3D printing of masks and ventilators.</li><li><strong>How important do you think MedTech is in delivering high levels of health care?</strong><br>Technological advances are pivotal to shifts in our practice in healthcare. Within my own field of neurosurgery, for example, the introduction of CT/MRI and the surgical microscope in the 1960’s were the drivers for “microneurosurgery” that defines the practice until this day. However, controversially, I think the role of MedTech can actually be often overstated. Some of the most important advances in patient outcomes have come not from technological “product innovation”, but from better healthcare processes with existing resources, that is “process innovation”, such as the WHO checklist.</li><li><strong>Tell us about your journey into the MedTech world (what inspired you) and how did you find the transition between what you were doing and MedTech.</strong> <br>I always have an interest in technology, and have been extremely lucky being born at the right time. Firstly, I was able to take advantage of things like the internet and smartphones as soon as they became usable for the general public but before they were mainstream (and no longer novel). Secondly, I was among the first cohort to have the option of undertaking an integrated academic training pathway — otherwise, I probably wouldn’t have been competitive enough to get the posts now (!). They also allowed me time to focus on MedTech at each stage of my career. Lastly, my PhD at Imperial with Lord Ara Darzi was, I think, something of a golden period — with many of my contemporaries there going on to either found or lead MedTech companies such as DeepMind, VineHealth, Digital Surgery, Intuitive, Auris etc. — this has made it much easier for me to collaborate with industry.</li><li><strong>What did you find your biggest barrier to be (If any)?</strong> <br>There are many barriers to new technologies — anything brought to market obviously has to be safe and effective, but also (often less evaluated) has to be acceptable to patients, usable by clinicians, and economically viable. The last point is extremely important and often forgotten in academia — the cost of bringing a complex robot to market is tens or even hundreds of millions of pounds. Therefore, if the market is small e.g., neurosurgery, it just doesn’t make sense to develop new tech.</li><li><strong>Tell us about your ongoing projects</strong>.<br>My clinical focus is on brain surgery, and particularly on its keyhole and endoscopic approaches. My research interest is in technology, especially augmented reality, robotics, and AI. I am also more broadly interested in the process of innovation in an abstract way.</li><li><strong>What is the future of MedTech, and do you think it’s heading towards the right direction?</strong><br>I think technology will always play a role in the advancement of healthcare, but my prediction would be that we will see less of large, complex, and very expensive multipurpose devices (such as robots). Instead, we will replace them with a suite of smaller, simpler, and less expensive application-specific devices. Paradoxically, I think this will mean that MedTech will appear to “disappear”: it will fade into everyday usage rather than being a big deal. This can be analogous to what has happened with computing — people use smartphones as tools, but nobody acknowledges them as supercomputers(which they are by even quite recent standards).</li></ol><figure><img alt="" src="https://cdn-images-1.medium.com/max/787/0*p6m_Ytd-r8z4Xw3g" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1d855b009723" width="1" height="1" alt=""><hr><p><a href="https://medium.com/cambridge-medtech-foundation/interview-with-mr-hani-marcus-an-academic-consultant-neurosurgeon-1d855b009723">Interview with Mr Hani Marcus, an academic consultant neurosurgeon</a> was originally published in <a href="https://medium.com/cambridge-medtech-foundation">Cambridge MedTech Foundation</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Summary of MEDx 4 — Narrowing the Gap: Healthcare Digitalized]]></title>
            <link>https://medium.com/cambridge-medtech-foundation/summary-of-medx-4-narrowing-the-gap-healthcare-digitalized-ff00a855b49b?source=rss----b4599aa1c18a---4</link>
            <guid isPermaLink="false">https://medium.com/p/ff00a855b49b</guid>
            <category><![CDATA[healthcare-technology]]></category>
            <category><![CDATA[medtech]]></category>
            <category><![CDATA[ai]]></category>
            <category><![CDATA[medical-technology]]></category>
            <category><![CDATA[speakers]]></category>
            <dc:creator><![CDATA[Sze Mai Ng]]></dc:creator>
            <pubDate>Sat, 13 Feb 2021 04:33:34 GMT</pubDate>
            <atom:updated>2021-02-13T05:10:04.398Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Summary of MEDx 4 — Narrowing the Gap: Healthcare Digitalized</strong></h3><h4>We were delighted to have invited three speakers to present topics on digitising healthcare, including applying DeepMind A.I. to ophthalmology, telemedicine charity in Zambia as well as an algorithm to diagnose pneumonia in children. All of these can help increase healthcare accessibility to improve overall welfare in less developed countries.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/proxy/0*tCirfOyeiJhzHCzo" /></figure><p>With huge success from the previous MEDx, the Cambridge MedTech Foundation kicked off 2021 with our fourth MEDx in January, which was well received by more than 60 participants from medicine, engineering, entrepreneurship and various disciplines. We were extremely grateful for the presentation of the three speakers who have made awe-inspiring contributions towards narrowing health inequalities through ethical healthcare digitalisation.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fwww.youtube.com%2Fembed%2F2ESSrVxE3lA%3Ffeature%3Doembed&amp;display_name=YouTube&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D2ESSrVxE3lA&amp;image=https%3A%2F%2Fi.ytimg.com%2Fvi%2F2ESSrVxE3lA%2Fhqdefault.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=youtube" width="640" height="480" frameborder="0" scrolling="no"><a href="https://medium.com/media/5659e98f7b8235857f316936a44f4617/href">https://medium.com/media/5659e98f7b8235857f316936a44f4617/href</a></iframe><p>Our first speaker, Dr. Pearse Keane from Moorefield’s Eye Hospital, talked about his collaborations with DeepMind on optical coherence tomography and its usage in retinal disease diagnosis and treatment, shedding light on the pioneering role of ophthalmology in medical A.I. to create substantial improvements in healthcare accessibility.</p><p>Up next was Huw Jones detailing his experiences in founding and leading Virtual Doctors, a telemedicine charity based in Zambia. He drew from his 30 years of work experience in local primary healthcare in rural Africa and gut-wrenching personal encounters, which has inspired him to embark on his journey to narrow healthcare gaps in less developed countries.</p><p>Lastly, Elina Naydenova, the co-founder of Feebris, introduced her ground-breaking algorithms to diagnose pneumonia in children from a single sensor-driven examination, enabling early detection of the global top infectious killer and proactive reduction in financial burdens on both individual patients and the healthcare system holistically.</p><p>In addition, we were delighted to have two students pitching their ideas for potential MedTech development during the Soapbox session, which has initiated extensive networking and discussion among our participants.</p><p>MEDx would not have been possible without the active participation and interaction of our audience. Thank you so much for joining us, and we look forward to seeing you again in MEDx 5 in March. Stay tuned!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ff00a855b49b" width="1" height="1" alt=""><hr><p><a href="https://medium.com/cambridge-medtech-foundation/summary-of-medx-4-narrowing-the-gap-healthcare-digitalized-ff00a855b49b">Summary of MEDx 4 — Narrowing the Gap: Healthcare Digitalized</a> was originally published in <a href="https://medium.com/cambridge-medtech-foundation">Cambridge MedTech Foundation</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Innovation Programme 2019/20]]></title>
            <link>https://medium.com/cambridge-medtech-foundation/innovation-programme-2019-20-c69947ff2023?source=rss----b4599aa1c18a---4</link>
            <guid isPermaLink="false">https://medium.com/p/c69947ff2023</guid>
            <category><![CDATA[innovation-program]]></category>
            <category><![CDATA[medtech]]></category>
            <category><![CDATA[education]]></category>
            <category><![CDATA[cambridge]]></category>
            <category><![CDATA[innovation]]></category>
            <dc:creator><![CDATA[Daniel Kottmann]]></dc:creator>
            <pubDate>Tue, 09 Feb 2021 11:04:40 GMT</pubDate>
            <atom:updated>2021-02-09T11:04:40.842Z</atom:updated>
            <content:encoded><![CDATA[<blockquote><strong><em>“A valuable educational experience for anyone interested in medical innovation.”</em></strong></blockquote><blockquote>3rd year Medical student</blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*0JWeACb-Q3BCf8WK.png" /></figure><p>After the success of the first Innovation Programme in 2018/19, we started another round of the Programme in Michaelmas 2019. <strong>Six student teams</strong> with different backgrounds worked on three clinical problems over the course of 12-weeks and pitched their innovative MedTech concepts to a panel of judges.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*3WJxJSW_51K4AiFS" /></figure><p>From 70 applications, <strong>35 students</strong> we selected to participate in the programme, of which half were postgraduates and most students came from a medical background. Other disciplines included sciences, engineering and business. Diversity of educational backgrounds is a key component of our programme.</p><p>Six interdisciplinary teams worked on <strong>three different clinical problems</strong>:</p><ul><li>Improving Transcatheter Aortic Valve Replacement</li><li>Re-imagining the Stoma</li><li>Creating Deformable Instruments for Neurosurgery</li></ul><blockquote><strong><em>“The Innovation Programme introduced me to what it takes to be an entrepreneur in the MedTech sector.”</em></strong></blockquote><blockquote>2nd year PhD student in Biophysical Chemistry</blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*bet4GoAHs-agsXcR.jpg" /></figure><p>Over the course of the programme, our partners from <strong>Clinical Engineering Innovation</strong> at Addenbrooke’s Hospital lectured about how to generate a concept for medical devices. The <strong>Entrepreneurship Center at the Judge Business School</strong> taught our students about opportunity evaluation, the business model canvas and effective teamwork. Moreover, students learned how to pitch themselves and their ideas, as well as how to communicate their work to students from other disciplines. Teams were mentored by clinicians involved in their project area, experts in clinical engineering and mentors from the <strong>Cambridge Accelerate</strong> programme.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*1mLlXfh1ch_JYylW.png" /></figure><p>At the end of the programme, all teams presented their work to all students and a panel of judges, consisting of <strong>Dr Peter Jarrit</strong> (Deputy Director at the NIHR Brain Injury MIC), <strong>Dr Mark Slack</strong> (co-founder and CMO of CMR Surgical) and <strong>Dr Ravi Solanki</strong> (founder of Primera Impact). The judges were impressed with the ideas of the students. Some teams decided to continue with their projects, one team working on improving Transcatheter Aortic Valve Replacement by creating a new surgical device was invited to present their work at an international conference.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*Am11qwsr9MB5ZJAo.jpg" /><figcaption>The participants of the 2019/20 programme at the Final Pitch Event</figcaption></figure><p>The students thoroughly enjoyed the programme, most students say they developed essential skills to develop innovative solutions in the MedTech field and that they now think more innovative. <strong>Over</strong> <strong>95% would recommend the programme</strong> to their friends.</p><blockquote><strong><em>“The Innovation Programme provided me with a unique insight into the entrepreneurial side of medicine and gave me the rare opportunity to collaborate with students from vastly different disciplines, while also giving me the skills and confidence to innovate in my future career.”</em></strong></blockquote><blockquote>3rd year Medicine and Neuroscience student</blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*f2drziy4J3CYBH86.jpg" /></figure><p>The 2019/20 Innovation Programme was organised by the Cambridge MedTech Foundation, <strong>Max Stewart</strong> (6th year Medical student) and <a href="https://www.linkedin.com/in/danielkottmann/"><strong>Daniel Kottmann</strong></a> (1st year PhD student in Medicine). It was supported by our academic partners the NIHR Brain Injury MIC, Clinical Engineering Innovation at Addenbrooke’s Hospital, the Entrepreneurship Centre at the Cambridge Judge Business School, and proudly supported by Eakin Healthcare.</p><p>Interested in applying or getting involved? <a href="https://cam.medtechfoundation.org/index.php/ip/">Visit our website to find out more.</a></p><p><strong>About the Innovation Programme</strong></p><p>The Innovation Programme is a 12-week educational programme providing both an introduction to the landscape of medical device development and experience of interdisciplinary teamwork. <a href="https://cam.medtechfoundation.org/index.php/ip/">Find out more.</a></p><p><strong>About the Cambridge MedTech Foundation</strong></p><p>We are a student-run society at the University of Cambridge with the aim to educate, inspire and connect the next generation of healthcare innovators. <a href="https://cam.medtechfoundation.org/">Visit our website.</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c69947ff2023" width="1" height="1" alt=""><hr><p><a href="https://medium.com/cambridge-medtech-foundation/innovation-programme-2019-20-c69947ff2023">Innovation Programme 2019/20</a> was originally published in <a href="https://medium.com/cambridge-medtech-foundation">Cambridge MedTech Foundation</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Introuction to Organoid technology]]></title>
            <link>https://medium.com/cambridge-medtech-foundation/introuction-to-organoid-technology-7e37c5cd70bf?source=rss----b4599aa1c18a---4</link>
            <guid isPermaLink="false">https://medium.com/p/7e37c5cd70bf</guid>
            <category><![CDATA[articles]]></category>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[medtech]]></category>
            <category><![CDATA[organoid]]></category>
            <category><![CDATA[biotechnology]]></category>
            <dc:creator><![CDATA[Sze Mai Ng]]></dc:creator>
            <pubDate>Tue, 22 Dec 2020 12:43:36 GMT</pubDate>
            <atom:updated>2020-12-22T12:43:52.055Z</atom:updated>
            <content:encoded><![CDATA[<h3>Introduction to Organoid technology</h3><h4>Organoid technology has been developing in recent years to overcome the challenges brought about while conducting investigations on human biology using previous model systems such as 2D cell printing and animal models. Its influences on modelling disease progression, personalised and regenerative medicine are far-reaching and provide new insights towards our understanding of the human body.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/0*eKwn0hfqPGKhfZ4V.jpg" /><figcaption>Intestinal organoid. Taken from: <a href="https://www.stemcell.com/technical-resources/area-of-interest/organoid-research.html">https://www.stemcell.com/technical-resources/area-of-interest/organoid-research.html</a></figcaption></figure><p>Model systems of the human body have been used in the past to facilitate understanding of signalling mechanisms at the cellular level, to aid in understanding of pathophysiology for diseases and development in targeted drugs.</p><p>However, previous model systems have limitations, such as inaccurate result extrapolation from animals to humans, ethical dilemmas, as well as the inability of 2D cell printing to show cellular self-organisation in the way our organs work. This leads to the need for 3D culture systems — organoids.</p><p>Organoids are derived from stem cells. Through creating a suitable environment ex-vivo, stem cells are stimulated to divide indefinitely and differentiate into different cell types, which self-organise into miniature organs that resemble those in the human body.</p><p><strong>Modelling disease progression</strong></p><p>Through monitoring the growth of organoids, which follow a developmental progression similar to an embryo, we may gain insight into the effect of pathology on embryonic development.</p><p>For example, by exposing mini-brain organoids to Zika virus, scientists have gained an understanding of the preferential neural cell targets of the virus and thus the development of microcephaly in infants born of infected women.</p><p><strong>Personalised medicine</strong></p><p>Creating organoids from stem cells of patients with genetic diseases and conducting drug testing on the organoids can aid in the development of personalised treatments.</p><p>In cystic fibrosis, in which ciliated cells that normally remove mucus from the interior or organs are malfunctioning, organoids with lung ciliated cells can be derived from the stem cells of an affected patient. Such organoids then undergo tests for drugs that may improve the mucus-removing function of ciliated cells derived from the patient, and thereby achieving personalisation. These specialised drugs can then be prescribed to the patient for therapeutic purposes.</p><p><strong>Regenerative medicine</strong></p><p>Another application of organoid technology is potential transplantations of organoids to replace cells or organs damaged by irreversible progressive diseases.</p><p>New studies have shown that organoids grown in-vivo from intestinal stem cells may be engrafted to reconstruct certain structures in the intestine,to provide therapeutic effect for patients suffering from ulcerative colitis, a major branch of inflammatory bowel disease.</p><p>The application of technologies and experimental procedures developed in traditional model systems to human organoid systems can enhance our understanding of medicine through validations and rejection of hypotheses. It is believed that rapid technological advances in the field of organoids can lead to unprecedented opportunities.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=7e37c5cd70bf" width="1" height="1" alt=""><hr><p><a href="https://medium.com/cambridge-medtech-foundation/introuction-to-organoid-technology-7e37c5cd70bf">Introuction to Organoid technology</a> was originally published in <a href="https://medium.com/cambridge-medtech-foundation">Cambridge MedTech Foundation</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>